Company: INSP
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0001609550-25-000053
Chunk: 21

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 1
Chunk 21
---
, Inc. Notes to Consolidated Financial Statements (unaudited) (Table amounts in thousands, except share and per share amounts)

million of gain, net, respectively. For the nine-month periods ended September 30, 2025 and 2024 we recognized $1.0 million of gain and $0.1 million of loss, net, respectively. Any unrealized gains and losses due to translation adjustments are included in accumulated other comprehensive income within stockholders' equity in the consolidated balance sheets. We had $0.0 million and $0.2 million of unrecognized gain in our accumulated other comprehensive income balance as of September 30, 2025 and December 31, 2024, respectively.InvestmentsOur investments are classified as available-for-sale and consisted of the following:September 30, 2025AmortizedUnrealized GrossAggregateCostGainsLossesFair ValueShort-Term:Commercial paper$21,903 $24 $— $21,927 Corporate debt securities45,854 145 — 45,999 U.S. treasury debt securities141,612 213 (4)141,821 Short-term investments$209,369 $382 $(4)$209,747 Long-Term:Corporate debt securities$51,977 $139 $(10)$52,106 U.S. treasury debt securities36,111 150 (14)36,247 Long-term investments$88,088 $289 $(24)$88,353 December 31, 2024AmortizedUnrealized GrossAggregateCostGainsLossesFair ValueShort-Term:Commercial paper$19,806 $25 $— $19,831 Corporate debt securities47,226 80 (7)47,299 Certificates of deposit7,684 10 — 7,694 U.S. treasury debt securities220,283 346 (57)220,572 Short-term investments$294,999 $461 $(64)$295,396 Long-Term:Corporate debt securities$23,915 $59 $(49)$23,925 Asset-backed securities287 — — 287 U.S. treasury debt securities46,818 50 (85)46,783 Long-term investments$71,020 $109 $(134)$70,995 The following table shows all available-for-sale investments in an unrealized